All very interesting.It is highly unusual for a "performance rights"to be asked for at this stage.I have two theories.Firstly,because Xtoll has the potential for maybe 48 indercations, Big Pharmas may have suggested a total buyout as they would not want to be at the mercy of a small Bio Tech and it's shareholders for the lenght of time this would take.This then would be the only opportunity for Directors to get their fill.Secondly,and probably the most likley outcome will be a licencing agreement.On signing an agreement I believe that some board members will be replaced.ie Chairman(due for retirement) and CEO.Big Pharma will appoint a non executive Chairman and maybe CEO and others as well.Again in this senaro this would be about their only chance to feather their nests at our expense.I also believe the results will be "exceptional".
CBZ Price at posting:
62.7¢ Sentiment: Hold Disclosure: Held
